Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-14-000105

President & CEO returned 2,048 shares (to the company)

  • President & CEO acquired 26,978 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CONCANNON BRIAN · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-10-22 Grant or award : show line 1 in the form +26,978 157,285 D
2014-10-24 Returned to the company : show line 2 in the form −2,048 $35.44 $72,581 155,237 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-10-22 Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) +119,731 $34.75 2024-10-22 119,731 119,731 D
2014-10-22 Grant or award : show line 4 in the form Performance Shares +53,956 $0.00 2017-12-31 53,956 103,956 D
Loading xslF345X03/edgardoc.xml…